PA
FDMT icon

Profund Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Profund Advisors’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
31,911
+1,060
+3% +$9.22K 0.01% 753
2025
Q4 		$231K Buy
+30,851
New +$313K 0.01% 1072
2024
Q4 		– Sell
-18,142
Closed -$196K – 1142
2024
Q3 		$196K Buy
18,142
+180
+1% +$2.99K 0.01% 1057
2024
Q2 		$377K Sell
17,962
-6,484
-27% -$163K 0.01% 594
2024
Q1 		$779K Buy
24,446
+9,990
+69% +$255K 0.03% 427
2023
Q4 		$293K Sell
14,456
-6,598
-31% -$86.8K 0.01% 792
2023
Q3 		$268K Sell
21,054
-7,725
-27% -$129K 0.01% 722
2023
Q2 		$520K Buy
28,779
+3,700
+15% +$68.1K 0.03% 500
2023
Q1 		$431K Buy
+25,079
New +$488K 0.03% 544

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return